Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CVS Health (CVS)

CVS Health Q4 revenue up 8.2%, adjusted EPS $1.09 vs $1.19; cash flow guide cut

Mixed Impact 4 of 5 earnings Written later

CVS Health reported fourth-quarter and full-year 2025 results, with revenue rising to $105.7 billion in the quarter and $402.1 billion for the year. Adjusted EPS fell to $1.09 in the quarter but rose to $6.75 for the full year, while full-year GAAP diluted EPS fell to $1.39 after a $5.7 billion goodwill impairment. The company confirmed its 2026 EPS guidance but lowered its cash flow from operations guidance to at least $9.0 billion from at least $10.0 billion.

Key points

  • Q4 2025 total revenues were $105.7 billion, up 8.2%, while adjusted EPS was $1.09 versus $1.19 a year earlier, primarily due to lower adjusted operating income in Health Care Benefits.
  • Full-year 2025 GAAP diluted EPS was $1.39 versus $3.66, reflecting a $5.7 billion goodwill impairment; full-year adjusted EPS rose to $6.75 from $5.42.
  • 2026 guidance: GAAP diluted EPS of $5.94 to $6.14 and adjusted EPS of $7.00 to $7.20 were confirmed; cash flow from operations guidance was updated to at least $9.0 billion from at least $10.0 billion.
  • The results were released February 10, 2026 as Exhibit 99.1 and signed by CFO Brian O. Newman; 2025 cash flow from operations was $10.6 billion.

The filing

CompanyCVS Health (CVS)
Form8-K, current report
Filed with the SECFeb 10, 2026, 6:31 AM ET
Accession number0000064803-26-000009

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 10, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.